Product Information

VENLAFAXINE HCL ER 225 MG TAB is a generic product labeled by Chartwell RX LLC, priced at $0.4614 per EA under NDC 62135053130. Its NADAC has been published 163 times since Jul 12, 2023.

FDA first approved this application on Oct 31, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VENLAFAXINE HCL ER 225 MG TAB

venlafaxine hydrochloride
$0.4614per EA

Strength

225 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135053130

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

VENLAFAXINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209193

FDA Approved

10/31/2019

TE Code

AB

On Market Since

12/26/2019

Pharmacological Classes

Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for VENLAFAXINE HCL ER 225 MG TAB has been published 163 times since Jul 12, 2023, and over the history we have for it it has declined 40.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4614 per EA
All-time high$1.2074 (Jan 10, 2024)
All-time low$0.4592 (Nov 20, 2024)
52-week high$0.6770
52-week low$0.4614
Median price$0.6675
Average price$0.6679
Largest weekly change+43.9% (Oct 18, 2023)
Weeks tracked163
Tracking sinceJul 12, 2023

Price History

1W

-7.8%

1M

-7.8%

3M

-12.8%

6M

-7.1%

1Y

-31.8%

3Y

-46.7%

5Y

N/A

All

-40.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of VENLAFAXINE HCL ER 225 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 225 MG TAB, manufactured by Chartwell RX LLC, is $0.4614 per EA (NDC 62135053130), effective Aug 19, 2026.

How has the price of VENLAFAXINE HCL ER 225 MG TAB changed over time?

Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 225 MG TAB has declined 40.8%. It has been tracked across 163 weekly CMS publications since Jul 12, 2023.

What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 225 MG TAB?

Since Jul 12, 2023, the NADAC for VENLAFAXINE HCL ER 225 MG TAB has ranged from a low of $0.4592 (Nov 20, 2024) to a high of $1.2074 (Jan 10, 2024), with a median of $0.6675 per EA.

Are there cheaper alternatives to VENLAFAXINE HCL ER 225 MG TAB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VENLAFAXINE HCL ER 225 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures VENLAFAXINE HCL ER 225 MG TAB?

VENLAFAXINE HCL ER 225 MG TAB (NDC 62135053130) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.